Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases Versus Chemotherapy Alone

NCT05322486 is registered in ClinicalTrials.gov with State Scientific Centre of Coloproctology, Russian Federation as lead sponsor.

NCT NCT05322486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases Versus Chemotherapy Alone
Lead sponsor
State Scientific Centre of Coloproctology, Russian Federation
Phase
Observational
Overall status
Unknown status
Start date
October 29, 2020
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonic disease, colorectal neoplasms, digestive system diseases, digestive system neoplasms, gastrointestinal diseases, gastrointestinal neoplasms, intestinal diseases, intestinal neoplasms, neoplasm metastasis, neoplasms, neoplasms by site, neoplasms, second primary, rectal diseases